GlassScriptPhysician profile
Mariam Gamal Wassef
NPI 1033475249
$27,065.03
in general payments reported to CMS, 2019-2025
37 companies · $4,165 in 2025
The $4,165 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $3,548 · 2021: $508 · 2022: $891 · 2023: $2,078 · 2024: $1,127 · 2025: $4,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,383 · Travel and Lodging: $2,987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,383.31 |
| Travel and Lodging | $2,986.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $12,840.48 | 2019-2020 | |
| Medtronic, INC. | $5,102.30 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Selectsecure, Micra |
| Boston Scientific Corporation | $3,649.87 | 2019-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Abbott Laboratories | $1,968.22 | 2019-2025 | Amplatzer Amulet, Gallant, Aveir |
| Medical Device Business Services, INC. | $1,093.41 | 2019 | |
| Irhythm Technologies, INC. | $356.38 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $258.23 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $151.83 | 2023-2024 | Optimizer, Optimizer |
| Cvrx, INC. | $132.50 | 2021-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $125.87 | 2021-2023 | Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.51 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $110.74 | 2021-2025 | Camzyos |
| Smith+Nephew, INC. | $104.70 | 2025 | Stravix |
| Sanofi-Aventis U.S. LLC | $103.06 | 2022-2023 | |
| Abiomed | $88.42 | 2023-2024 | Impella |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariam Wassef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.